Carl Schmidt, MD, FACS

Professor and Chairman

Organization:

West Virginia University School of Medicine

Department:

Surgery

Classification:

Clinical Faculty

Chief of Surgical Oncology

Organization:

West Virginia University WVU Cancer Institute

Department:

WVU Cancer Institute Clinics

Classification:

Clinical Faculty

Member

Organization:

West Virginia University WVU Cancer Institute

Department:

WVU Cancer Institute Research Programs

Classification:

Clinical Faculty

• MD, University of Michigan

Education
BS University of Michigan 1992-1995
MD University of Michigan Medical School 1995-1999
MS Vanderbilt University School of Medicine 2002-2004

Postgraduate/Postdoctoral Training 
Surgical Residency July 1999 to June 2006
Department of Surgery, Vanderbilt University Medical Center, Nashville, TN

Surgical Oncology Residency Research Fellowship July 2002 to June 2004
Department of Surgery, Vanderbilt University Medical Center, Nashville, TN

Surgical Oncology Fellowship July 2006 to June 2008
Memorial Sloan-Kettering Cancer Center, New York, NY

Board Certification
General Surgery, American Board of Surgery expires December 2027

Publications

1: Sestito M, Pratt H, Schmidt C, Thomay A. Recent advances for treatment of upper gastrointestinal malignancy. J Surg Oncol. 2024 Jan;129(1):48-62. doi: 10.1002/jso.27530. Epub 2023 Nov 27. PMID: 38010879.

2: Wasef K, Hudnall A, Schmidt CR, Marsh JW, Boone BA. Robotic modified Strong procedure for superior mesenteric artery syndrome. Clin Case Rep. 2023 Jul 17;11(7):e7651. doi: 10.1002/ccr3.7651. PMID: 37465243; PMCID: PMC10350670.

3: Rao P, Niemann B, Szeligo B, Ivey AD, Murthy P, Schmidt CR, Boone BA. Acute pancreatitis induces a transient hypercoagulable state in murine models. Pancreatology. 2023 Apr;23(3):306-313. doi: 10.1016/j.pan.2023.02.007. Epub 2023 Mar 3. PMID: 36898897; PMCID: PMC10121939.

4: Hathaway QA, Lakhani DA, Balar AB, Santiago SP, Krafft MR, Zitun M, Schmidt CR, Smith KT, Kim C. Distal cholangiocarcinoma: case report and brief review of the literature. Radiol Case Rep. 2022 Nov 22;18(2):423-429. doi: 10.1016/j.radcr.2022.10.072. PMID: 36444360; PMCID: PMC9699922.

5: Paniccia A, Polanco PM, Boone BA, Wald AI, McGrath K, Brand RE, Khalid A, Kubiliun N, O'Broin-Lennon AM, Park WG, Klapman J, Tharian B, Inamdar S, Fasanella K, Nasr J, Chennat J, Das R, DeWitt J, Easler JJ, Bick B, Singh H, Fairley KJ, Sarkaria S, Sawas T, Skef W, Slivka A, Tavakkoli A, Thakkar S, Kim V, Vanderveldt HD, Richardson A, Wallace MB, Brahmbhatt B, Engels M, Gabbert C, Dugum M, El-Dika S, Bhat Y, Ramrakhiani S, Bakis G, Rolshud D, Millspaugh G, Tielleman T, Schmidt C, Mansour J, Marsh W, Ongchin M, Centeno B, Monaco SE, Ohori NP, Lajara S, Thompson ED, Hruban RH, Bell PD, Smith K, Permuth JB, Vandenbussche C, Ernst W, Grupillo M, Kaya C, Hogg M, He J, Wolfgang CL, Lee KK, Zeh H, Zureikat A, Nikiforova MN, Singhi AD. Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts. Gastroenterology. 2023 Jan;164(1):117-133.e7. doi: 10.1053/j.gastro.2022.09.028. Epub 2022 Oct 6. PMID: 36209796; PMCID: PMC9844531.

6: Sharma NK, Okakpu U, Murthy J, Wei LM, Lopez-Solis R, Schmidt C, Badhwar V, Marsh JW. Case report: Surgical resection of a retro-hepatic leiomyosarcoma involving atrial reconstruction, cardiopulmonary bypass, ex vivo tumor resection, and liver re-implantation. Front Surg. 2022 Nov 7;9:1037312. doi: 10.3389/fsurg.2022.1037312. PMID: 36420407; PMCID: PMC9676270.

7: Chakedis JM, Dillhoff ME, Schmidt CR, Rajasekera PV, Evans DC, Williams TM, Guttridge DC, Talbert EE. Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer-induced cachexia. JCSM Rapid Commun. 2022 Jul-Dec;5(2):254-265. doi: 10.1002/rco2.68. Epub 2022 Jun 20. PMID: 36591536; PMCID: PMC9797184.

8: Schmidt CR. Innovations defining the future of gastric cancer-Introduction. J Surg Oncol. 2022 Jun;125(7):1077-1078. doi: 10.1002/jso.26871. PMID: 35481917.

9: Schmidt CR. Innovations defining the future of gastric cancer: Summary. J Surg Oncol. 2022 Jun;125(7):1183. doi: 10.1002/jso.26873. PMID: 35481915.

10: Tham E, Schmidt C. Are Textbook Outcomes after Hepatectomy Only Possible at a Specific Weight? Ann Surg Oncol. 2022 Apr 16. doi: 10.1245/s10434-022-11739-2. Epub ahead of print. PMID: 35430660.

11: Spolverato G, Capelli G, Lorenzoni G, Gregori D, Squires MH, Poultsides GA, Fields RC, Bloomston MP, Weber SM, Votanopoulos KI, Acher AW, Jin LX, Hawkins WG, Schmidt CR, Kooby DA, Worhunsky DJ, Saunders ND, Levine EA, Cho CS, Maithel SK, Pucciarelli S, Pawlik TM. Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer. Ann Surg Oncol. 2022 Feb;29(2):1220-1229. doi: 10.1245/s10434-021-10768-7. Epub 2021 Sep 14. PMID: 34523000.

12: Wiseman JT, Chakedis J, Beal EW, Paredes A, McElhany A, Fang A, Manilchuk A, Ellison C, Van Buren G, Pawlik TM, Schmidt CR, Fisher WE, Dillhoff M. Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis. J Gastrointest Surg. 2021 Dec;25(12):3119-3129. doi: 10.1007/s11605-021-05014-0. Epub 2021 May 4. PMID: 33948858.

13: Casciani F, Trudeau MT, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Christein JD, Falconi M, Fernandez-Del Castillo C, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, Partelli S, Wolfgang CL, Zureikat AH, Vollmer CM; Pancreas Fistula Study Group. The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. Surgery. 2021 Oct;170(4):1195-1204. doi: 10.1016/j.surg.2021.03.044. Epub 2021 Apr 28. PMID: 33931208.

14: Ryoo DY, Eskander MF, Hamad A, Li Y, Cloyd J, Manilchuk A, Tsung A, Pawlik TM, Dillhoff M, Schmidt C, Ejaz A. Mitigation of the Robotic Pancreaticoduodenectomy Learning Curve through comprehensive training. HPB (Oxford). 2021 Oct;23(10):1550-1556. doi: 10.1016/j.hpb.2021.03.010. Epub 2021 Apr 8. PMID: 33903049.

15: Rao P, Schmidt CR, Boone BA. Robot Assisted Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer: Surgical Planning and Technique. J Vis Exp. 2021 Aug 14;(174). doi: 10.3791/62232. PMID: 34459807.

16: Mullens CL, Van Horn AL, Marsh JW, Hogg ME, Thomay AA, Schmidt CR, Boone BA. Development of a Senior Medical Student Robotic Surgery Training Elective. J Med Educ Curric Dev. 2021 Jun 29;8:23821205211024074. doi: 10.1177/23821205211024074. PMID: 34263057; PMCID: PMC8246496.

17: Casciani F, Trudeau MT, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Christein JD, Falconi M, Fernandez-Del Castillo C, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Malleo G, Partelli S, Salem RR, Stauffer JA, Wolfgang CL, Zureikat AH, Vollmer CM Jr; Pancreas Fistula Study Group. Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development. Surgery. 2021 Apr;169(4):708-720. doi: 10.1016/j.surg.2020.11.022. Epub 2020 Dec 30. PMID: 33386129.

18: Schmidt CR, Harris BR, Musgrove KA, Rao P, Marsh JW, Thomay AA, Hogg ME, Zeh HJ, Zureikat AH, Boone BA. Formal robotic training diminishes the learning curve for robotic pancreatoduodenectomy: Implications for new programs in complex robotic surgery. J Surg Oncol. 2021 Feb;123(2):375-380. doi: 10.1002/jso.26284. Epub 2020 Nov 2. PMID: 33135785; PMCID: PMC7902319.

19: Lu F, Shah PA, Rao A, Gifford-Hollingsworth C, Chen A, Trey G, Soryal M, Talat A, Aslam A, Nasir B, Choudhry S, Ishtiaq R, Sanoff H, Conteh LF, Noonan A, Hu KQ, Schmidt C, Fu M, Civan J, Xiao G, Lau DT, Lu X. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma. Clin Transl Gastroenterol. 2020 Dec;11(12):e00271. doi: 10.14309/ctg.0000000000000271. PMID: 33512798; PMCID: PMC7685967.

20: Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection. HPB (Oxford). 2020 Aug;22(8):1149-1157. doi: 10.1016/j.hpb.2019.11.009. Epub 2019 Dec 9. PMID: 31822386; PMCID: PMC10182413.

21: Squires MH, Worth PJ, Konda B, Shah MH, Dillhoff ME, Abdel-Misih S, Norton JA, Visser BC, Dua M, Pawlik TM, Schmidt CR, Poultsides G, Cloyd JM. Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors. Pancreas. 2020 Mar;49(3):355-360. doi: 10.1097/MPA.0000000000001500. PMID: 32132509.

22: Krishna SG, Hart PA, Malli A, Kruger AJ, McCarthy ST, El-Dika S, Walker JP, Dillhoff ME, Manilchuk A, Schmidt CR, Pawlik TM, Porter K, Arnold CA, Cruz- Monserrate Z, Conwell DL. Endoscopic Ultrasound-Guided Confocal Laser Endomicroscopy Increases Accuracy of Differentiation of Pancreatic Cystic Lesions. Clin Gastroenterol Hepatol. 2020 Feb;18(2):432-440.e6. doi: 10.1016/j.cgh.2019.06.010. Epub 2019 Jun 18. PMID: 31220640.

23: Armstrong EA, Beal EW, Lopez-Aguiar AG, Poultsides G, Cannon JG, Rocha F, Crown A, Barrett J, Ronnkleiv-Kelly S, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems MV, Maithel SK, Schmidt CR, Pawlik TM, Dillhoff M. Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group. Am Surg. 2019 Dec 1;85(12):1334-1340. PMID: 31908214; PMCID: PMC10188290.

24: Owen DH, Patel S, Wei L, Phay JE, Shirley LA, Kirschner LS, Schmidt C, Abdel-Misih S, Brock P, Shah MH, Konda B. Metastatic Adrenocortical Carcinoma: a Single Institutional Experience. Horm Cancer. 2019 Dec;10(4-6):161-167. doi: 10.1007/s12672-019-00367-0. Epub 2019 Aug 29. PMID: 31468469; PMCID: PMC10355711.

25: Dave A, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Ronnekleiv-Kelly S, Rendell VR, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems M, Maithel SK, Pawlik TM, Schmidt CR, Dillhoff ME. Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group. J Gastrointest Surg. 2019 Nov;23(11):2225-2231. doi: 10.1007/s11605-019-04120-4. Epub 2019 Apr 2. PMID: 30941685; PMCID: PMC10178764.

26: Talbert EE, Cuitiño MC, Ladner KJ, Rajasekerea PV, Siebert M, Shakya R, Leone GW, Ostrowski MC, Paleo B, Weisleder N, Reiser PJ, Webb A, Timmers CD, Eiferman DS, Evans DC, Dillhoff ME, Schmidt CR, Guttridge DC. Modeling Human Cancer-induced Cachexia. Cell Rep. 2019 Aug 6;28(6):1612-1622.e4. doi: 10.1016/j.celrep.2019.07.016. PMID: 31390573; PMCID: PMC6733019.

27: Ecker BL, Vollmer CM Jr, Behrman SW, Allegrini V, Aversa J, Ball CG, Barrows CE, Berger AC, Cagigas MN, Christein JD, Dixon E, Fisher WE, Freedman-Weiss M, Guzman-Pruneda F, Hollis RH, House MG, Kent TS, Kowalsky SJ, Malleo G, Salem RR, Salvia R, Schmidt CR, Seykora TF, Zheng R, Zureikat AH, Dickson PV. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma. JAMA Surg. 2019 Aug 1;154(8):706-714. doi: 10.1001/jamasurg.2019.1170. PMID: 31141112; PMCID: PMC6547142.

28: Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Schmidt CR, Maithel SK, Pawlik TM; United States Neuroendocrine Tumor Study Group. Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group. J Surg Oncol. 2019 Aug;120(2):231-240. doi: 10.1002/jso.25481. Epub 2019 Apr 18. PMID: 31001868.

29: Beal EW, Bagante F, Paredes A, Akgul O, Merath K, Cua S, Dillhoff ME, Schmidt CR, Abel E, Scrape S, Ejaz A, Pawlik TM. Perioperative use of blood products is associated with risk of morbidity and mortality after surgery. Am J Surg. 2019 Jul;218(1):62-70. doi: 10.1016/j.amjsurg.2018.11.015. Epub 2018 Nov 27. PMID: 30509453.

30: Lopez-Aguiar AG, Ethun CG, Pawlik TM, Tran T, Poultsides GA, Isom CA, Idrees K, Krasnick BA, Fields RC, Salem A, Weber SM, Martin RCG, Scoggins CR, Shen P, Mogal HD, Beal EW, Schmidt C, Shenoy R, Hatzaras I, Maithel SK. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol. 2019 Jun;26(6):1814-1823. doi: 10.1245/s10434-019-07306-x. Epub 2019 Mar 15. PMID: 30877497; PMCID: PMC10182408.

31: Villafane-Ferriol N, Baugh KA, McElhany AL, Van Buren G 2nd, Fang A, Tashakori EK, Reyes JEM, Cao HST, Silberfein EJ, Massarweh N, Hsu C, Barakat O, Schmidt C, Zyromski NJ, Dillhoff M, Villarreal JA, Fisher WE. Evidence Versus Practice in Early Drain Removal After Pancreatectomy. J Surg Res. 2019 Apr;236:332-339. doi: 10.1016/j.jss.2018.11.048. Epub 2019 Jan 4. PMID: 30694774; PMCID: PMC6377814.

32: Guzman-Pruneda FA, Husain SG, Jones CD, Beal EW, Porter E, Grove M, Moffatt- Bruce S, Schmidt CR. Compliance with preoperative care measures reduces surgical site infection after colorectal operation. J Surg Oncol. 2019 Mar;119(4):497-502. doi: 10.1002/jso.25346. Epub 2018 Dec 24. PMID: 30582613.

33: Kimbrough CW, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Crown A, Abbott DE, Fisher AV, Fields RC, Krasnick BA, Idrees K, Marincola-Smith P, Cho CS, Beems M, Maithel SK, Cloyd JM. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection. Surgery. 2019 Mar;165(3):657-663. doi: 10.1016/j.surg.2018.09.008. Epub 2018 Oct 28. PMID: 30377003; PMCID: PMC10182411.

34: Zhang XF, Wu Z, Cloyd J, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Margin status and long- term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group. Surgery. 2019 Mar;165(3):548-556. doi: 10.1016/j.surg.2018.08.015. Epub 2018 Sep 29. PMID: 30278986; PMCID: PMC10187058.

35: Merath K, Chen Q, Bagante F, Sun S, Akgul O, Idrees JJ, Dillhoff M, Schmidt C, Cloyd J, Pawlik TM. Variation in the cost-of-rescue among medicare patients with complications following hepatopancreatic surgery. HPB (Oxford). 2019 Mar;21(3):310-318. doi: 10.1016/j.hpb.2018.08.005. Epub 2018 Sep 25. PMID: 30266495.

36: Idrees JJ, Johnston FM, Canner JK, Dillhoff M, Schmidt C, Haut ER, Pawlik TM. Cost of Major Complications After Liver Resection in the United States: Are High-volume Centers Cost-effective? Ann Surg. 2019 Mar;269(3):503-510. doi: 10.1097/SLA.0000000000002627. PMID: 29232212.

37: Tran TB, Ethun CG, Pawlik TM, Schmidt C, Beal EW, Fields RC, Krasnick B, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Idrees K, Isom CA, Hatzaras I, Shenoy R, Maithel SK, Poultsides GA. Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma. Ann Surg Oncol. 2019 Feb;26(2):611-618. doi: 10.1245/s10434-018-7075-4. Epub 2018 Dec 11. PMID: 30539494.

38: Paredes AZ, Abdel-Misih S, Schmidt C, Dillhoff ME, Pawlik TM, Cloyd JM. Predictors of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2019 Feb;234:103-109. doi: 10.1016/j.jss.2018.09.022. Epub 2018 Oct 5. PMID: 30527460.

39: Ramsey ML, Talbert E, Ahn D, Bekaii-Saab T, Badi N, Bloomston PM, Conwell DL, Cruz-Monserrate Z, Dillhoff M, Farren MR, Hinton A, Krishna SG, Lesinski GB, Mace T, Manilchuk A, Noonan A, Pawlik TM, Rajasekera PV, Schmidt C, Guttridge D, Hart PA. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer. Pancreatology. 2019 Jan;19(1):80-87. doi: 10.1016/j.pan.2018.11.002. Epub 2018 Nov 10. PMID: 30497874; PMCID: PMC6613190.

40: Chakedis J, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola-Smith P, Cho C, Beems M, Pawlik TM, Maithel SK, Schmidt CR, Dillhoff M. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. J Gastrointest Surg. 2019 Jan;23(1):122-134. doi: 10.1007/s11605-018-3986-4. Epub 2018 Oct 17. PMID: 30334178; PMCID: PMC10183101.

41: Chen Q, Bagante F, Olsen G, Merath K, Idrees JJ, Beal EW, Akgul O, Cloyd J, Dillhoff M, Schmidt C, White S, Pawlik TM. Time to Readmission and Mortality Among Patients Undergoing Liver and Pancreatic Surgery. World J Surg. 2019 Jan;43(1):242-251. doi: 10.1007/s00268-018-4766-8. PMID: 30109390.

42: McDermott SM, Saunders ND, Schneider EB, Strosberg D, Onesti J, Dillhoff M, Schmidt CR, Shirley LA. Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases. J Surg Res. 2018 Dec;232:369-375. doi: 10.1016/j.jss.2018.06.058. Epub 2018 Jul 18. PMID: 30463743.

43: Chakedis J, Beal EW, Sun S, Galo J, Chafitz A, Davidson G, Reardon J, Dillhoff M, Pawlik TM, Abdel-Misih S, Bloomston M, Schmidt CR. Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases. J Surg Oncol. 2018 Dec;118(7):1065-1073. doi: 10.1002/jso.25249. PMID: 30376157.

44: Cerullo M, Chen SY, Gani F, Idrees J, Dillhoff M, Schmidt C, Canner JK, Cloyd J, Pawlik TM. The relationship of hospital market concentration, costs, and quality for major surgical procedures. Am J Surg. 2018 Dec;216(6):1037-1045. doi: 10.1016/j.amjsurg.2018.07.042. Epub 2018 Jul 25. PMID: 30060911.

45: Walston S, Salloum J, Grieco C, Wuthrick E, Diaz DA, Barney C, Manilchuk A, Schmidt C, Dillhoff M, Pawlik TM, Williams TM. Identifying Clinical Factors Which Predict for Early Failure Patterns Following Resection for Pancreatic Adenocarcinoma in Patients Who Received Adjuvant Chemotherapy Without Chemoradiation. Am J Clin Oncol. 2018 Dec;41(12):1185-1192. doi: 10.1097/COC.0000000000000452. PMID: 29727311; PMCID: PMC6215749.

46: Strosberg D, Schneider EB, Onesti J, Saunders N, Konda B, Shah M, Dillhoff M, Schmidt CR, Shirley LA. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors. Ann Surg Oncol. 2018 Nov;25(12):3613-3620. doi: 10.1245/s10434-018-6741-x. Epub 2018 Sep 4. PMID: 30182331.

47: Idrees JJ, Kimbrough CW, Rosinski BF, Schmidt C, Dillhoff ME, Beal EW, Bagante F, Merath K, Chen Q, Cloyd JM, Ellison EC, Pawlik TM. The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample. J Gastrointest Surg. 2018 Oct;22(10):1688-1696. doi: 10.1007/s11605-018-3826-6. Epub 2018 May 31. PMID: 29855870.

48: Hughes TM, Palmer EN, Capers Q, Abdel-Misih S, Harzmann A, Beal E, Woelfel I, Noria S, Agnese D, Dillhoff M, Grignol V, Howard JH, Shirley LA, Terando A, Schmidt C, Cloyd J, Pawlik T. Practices and Perceptions Among Surgical Oncologists in the Perioperative Care of Obese Cancer Patients. Ann Surg Oncol. 2018 Sep;25(9):2513-2519. doi: 10.1245/s10434-018-6564-9. Epub 2018 Jul 9. PMID: 29987611.

49: Merath K, Bagante F, Chen Q, Beal EW, Akgul O, Idrees J, Dillhoff M, Cloyd J, Schmidt C, Pawlik TM. The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis. J Gastrointest Surg. 2018 Sep;22(9):1538-1548. doi: 10.1007/s11605-018-3783-0. Epub 2018 May 7. PMID: 29736663.

50: Cloyd JM, Abdel-Misih S, Hays J, Dillhoff ME, Pawlik TM, Schmidt C. Impact of Synchronous Liver Resection on the Perioperative Outcomes of Patients Undergoing CRS-HIPEC. J Gastrointest Surg. 2018 Sep;22(9):1576-1584. doi: 10.1007/s11605-018-3784-z. Epub 2018 Apr 30. PMID: 29713875.

Book Chapters
ACS Operative Standards for Cancer Surgery vol. 2, Gastric Cancer, 2019
Lewis H, Schmidt C, Pawlik T, Minimally Invasive Liver Resection, UpToDate, 2020
Schmidt C, Blum Murphy M, Yao J, Crane C. Carcinoma of the stomach. Holland-Frei Cancer Medicine. John Wiley and Sons, 2016. 
Merchant N, Parikh A, Schmidt C, Beauchamp R. Cancer of the colon, rectum and anus. Textbook of Surgical Oncology.  Informa Healthcare, 2007.

Invited Lectures and Presentations
Moderator – “HPB/Upper GI Quick Shot Abstracts” Society of Surgical Oncology, Chicago, 2018
Robot Whipple Debate- Pro vs. Con – Amer Zureikat vs Carl Schmidt - Central Surgical Association, Columbus, OH, 2018
“Surgical Quality – Where to Focus?” Whitmarsh Lecture, Roger Williams Medical Center, Providence, RI 2017
“Power and Statistical Significance of Data in Clinical Trials” Radiologic Society of North America (RSNA), Chicago, IL, 2017
“Pancreas Cancer: Management of Surgical Options” 15th Annual Mid-South Cancer Symposium, Memphis, TN, 2017
“Management of Liver Metastatic Tumors” OSUWMC Update on Management of Liver Tumors, Columbus, OH, 2017
Moderator - “Advanced Practice Providers and an HPB Practice” Americas Hepato-Pancreato-Biliary Association, Miami, FL, 2017
“HCC: Epidemiology, Staging and Future Directions” Society of Interventional Radiology Annual Meeting, 2017, Washington DC
“Surgical and Locoregional Therapies for HCC” Ecuadorian Society of Surgery Annual Meeting 2016 – Quito, Ecuador

My clinical focus is liver, gastric and pancreas malignancies. As the leader for WVU’s program in Robotic Surgery, a high priority is development of innovative strategies for educating residents in Robotic Surgery. Our group is also working to expand efforts in Enhanced Recovery After Surgery (ERAS) for patients undergoing complex abdominal and pelvic operations. I also helped establish WVU Cancer Institute’s Oncology Quality Council. Through the WVU-CI network of hospitals, we have ongoing projects to improve cancer care for the rural WV population. I welcome working with a resident in any of these areas!

Medical Specialties

• Cancer / Oncology
• Surgery

Board Certifications

• Surgery, American Board of Surgery

Special Training

• Residency, General Surgery
  Vanderbilt University
• Fellowship, Surgical Oncology
  Memorial Sloan-Kettering Cancer Center